Atlas Trials

Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.

Clinical trial NCT00219024 · COMPLETED

Trial details

NCT number
NCT00219024
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2004-08-01
Primary completion
2005-06-01
Enrollment
2775

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.